CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 230 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,303,568 | +20.7% | 341,478 | -1.4% | 0.08% | +10.4% |
| Q2 2023 | $7,708,980 | +2.0% | 346,471 | -0.7% | 0.08% | +11.6% |
| Q1 2023 | $7,555,225 | +1.1% | 348,810 | -5.2% | 0.07% | -83.9% |
| Q4 2022 | $7,471,379 | -22.7% | 367,867 | -2.4% | 0.43% | +102.8% |
| Q3 2022 | $9,663,000 | +5.8% | 376,855 | -1.9% | 0.21% | +16.6% |
| Q2 2022 | $9,137,000 | +4.0% | 384,231 | -1.5% | 0.18% | +25.7% |
| Q1 2022 | $8,783,000 | – | 389,999 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,825,262 | $138,621 | 7.54% |
| Novo Holdings A/S | 3,377,768 | $68,602,468 | 4.28% |
| Parallel Advisors, LLC | 3,724,664 | $75,647,926 | 3.28% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $722 | 2.29% |
| Quantedge Capital Pte Ltd | 251,312 | $5,104,147 | 1.71% |
| S&T BANK/PA | 346,306 | $7,033 | 1.30% |
| Freshford Capital Management, LLC | 249,000 | $5,057,190 | 1.09% |
| Birchview Capital, LP | 50,000 | $1,016 | 0.72% |
| FAS Wealth Partners, Inc. | 306,276 | $6,220,466 | 0.70% |
| Bridge City Capital, LLC | 60,824 | $1,235 | 0.63% |